Roivant Sciences Net Change in Cash decreased by 3888.1% to -$57.79M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$133.30M | $500.75M | -$282.99M | -$152.10M | -$117.57M | -$343.82M | -$71.61M | -$242.47M | -$26.46M | $5.26B | $0.00 | -$857.15M | -$3.66B | -$27.20M | -$1.48B | -$1.45M | -$57.79M |
| QoQ Change | — | +475.7% | -156.5% | +46.3% | +22.7% | -192.5% | +79.2% | -238.6% | +89.1% | >999% | -100.0% | — | -327.5% | +99.3% | <-999% | +99.9% | <-999% |
| YoY Change | — | — | — | — | +11.8% | -168.7% | +74.7% | -106.2% | +92.3% | >999% | — | -253.5% | <-999% | -100.5% | -72.3% | +100.0% | — |